D-1525-2019 Class II Terminated
FDA drug recall D-1525-2019 was initiated by Geritrex, LLC on May 31, 2019 and is designated Class II. Reason for recall: cGMP Deviations: Products may have microbial contamination. The recall status is terminated (terminated Feb 2, 2024). Affected quantity: 7653 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Jul 31, 2019
- Initiation Date
- May 31, 2019
- Termination Date
- Feb 2, 2024
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 7653 bottles
Product description
Ritussin DM Double Strength, 4 FL. OZ. (118 mL), RIJ Pharmaceutical Corporation 40 Commercial Avenue Middletown, NY 10941
Reason for recall
cGMP Deviations: Products may have microbial contamination.
Distribution pattern
U.S.A. Nationwide
Code information
Lot #: 70611, Exp 6/19
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1525-2019
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026